She was told she might have cancer: How medicine pathologizes Black patients’ normal test results
A busy medical student, Vanessa Apea wasn’t her usual energetic self. So she dragged herself…
Category: genetics
Illumina lays out plan to boost growth by helping scientists interpret sequencing data
SAN DIEGO — The unwinding of Illumina’s ill-fated acquisition of Grail earlier this year left…
Scientists are starting to uncover how neighborhood can affect the biology of cancer
Where you live has a relationship to your odds of getting cancer and surviving cancer….
STAT+: 23andMe board rejects co-founder Anne Wojcicki’s offer to take company private
A special committee of the board of directors of 23andMe rejected an offer from the…
STAT+: Jim Wilson, gene therapy pioneer, departs Penn to set up new companies
Jim Wilson, a leading gene therapy researcher who has persisted through the field’s ups and…
STAT+: 23andMe co-founder Anne Wojcicki files to take company private
A trust controlled by 23andMe co-founder Anne Wojcicki has formally filed to take the genetic…
Opinion: Sponsored genetic testing programs are under fire, further complicating life for people with rare diseases
It takes years for most people with a rare disease to learn what is ailing…
Massive study of veterans’ DNA shows how diversity can help researchers decipher the genome
An expansive new study offers clear evidence that sequencing the genomes of diverse populations can…
STAT+: Broad Institute, facing end of Microsoft cloud contract, shuffles data science leadership
The Broad Institute of MIT and Harvard is perhaps best known for the trailblazing work…
Roche looks to have a competitive GLP-1 drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What are the odds we get an heir to Paxlovid?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Element Biosciences raises another massive round
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Can you get satiety with GLP-1s without the nausea?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
uniQure shares soar on Huntington’s data
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Lilly’s obesity drug looks more potent than Novo’s in observational study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
5 takeaways from the Human Genome Project investigation
The Human Genome Project was among the most ambitious scientific efforts in modern history, with…
The untold story of the Human Genome Project: How one man’s DNA became a pillar of genetics
STAT is co-publishing this investigation by Undark. They numbered 20 in all — 10 men…
The biotech news you missed this week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
One firm, two conflicting takes on Alnylam’s HELIOS-B
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The findings from Alnylam’s highly anticipated readout
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: New study bolsters evidence rare genetic mutation can delay early Alzheimer’s
For members of a large extended Colombian family, an early Alzheimer’s diagnosis is practically a…
A biotech’s binary bet ends badly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
FDA offers new guidelines for Covid-19 vaccine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
J.P. Morgan has officially jumped into early stage biotech investing
Want to stay on top of the science and politics driving biotech today? Sign up to get…
With Avidity and Pfizer, gene therapy enters a phase
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Illumina board agrees to spin off Grail, as divestment plans proceed
Illumina said Monday afternoon that its board of directors had approved a spin-off of its…
The surprising outperformance of a new drug against existing competitors, and other biotech updates
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biotech’s most interesting fundraisings from the last week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy
Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a…
Maryland takes first steps to cap drug costs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Lilly doubles down on radiopharma
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Black Americans’ risk for breast cancer gains clarity in analysis of 40,000 genomes
Hundreds of genetic variants can nudge someone’s risk of breast cancer up or down or…
STAT+: ChatGPT for genomes: introducing a CRISPR-designing generative AI
In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived…
Is Novavax a new meme stock?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Element Biosciences, an Illumina rival, on its genomics ambitions — and why it hasn’t gone public
SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit…
Genetic variant common among West African descendants contributes to large cardiovascular disease burden
Among cardiologists, it’s known that transthyretin cardiac amyloidosis, a type of heart disease, is caused…
We now know Tome’s gene editing target
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: First recipient of kidney transplant from genetically engineered pig has died, family says
Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has…
Yet another big financing round in immunology
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Pharma has over $500B in capital for deals
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Alzheimer’s risk gene APOE4 may cause a distinct form of the disease, study suggests
For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic…
STAT+: Moderna ends collaboration with CRISPR company Metagenomi, parts ways with gene editing chief
Three years ago, Moderna, flush with cash from Covid vaccine sales, announced it would start…
STAT+: Experimental gene therapy seems to alleviate skeletal defects tied to rare inherited disease, study shows
LONDON — In 2021, a team of Italian researchers reported that an experimental gene therapy…
STAT+: In a scientific first, researchers use CRISPR base editing to treat liver disease in fetal monkeys
The ambitious idea of using CRISPR to cure genetic diseases before birth is one step…
STAT+: 23andme CEO Anne Wojcicki moves to take company private
After a tumultuous experience on the public markets, 23andMe CEO Anne Wojcicki is moving to…
What the noses of mice can tell us about the inheritance of trauma
In the final year of World War II, Nazi troops starved the Netherlands in a…
STAT+: MassMutual is rolling out free genetic testing for members, a dicey area for life insurers
One of the country’s biggest life insurers is venturing into genetic testing, an area that’s…
How resurrecting extinct species might impact medicine
Want to stay on top of the science and politics driving biotech today? Sign up to get…